Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
ADC ID |
DRG0SBFOG
|
|||||
---|---|---|---|---|---|---|
ADC Name |
Anti-FGFR2/4 mAb-12422 SPDB-DM4
|
|||||
Synonyms |
Anti-FGFR2/4-mAb-12422-SPDB-DM4
Click to Show/Hide
|
|||||
Organization |
Novartis AG
|
|||||
Drug Status |
Investigative
|
|||||
Indication |
In total 3 Indication(s)
Breast cancer [ICD11:2C60-2C65]
Investigative
Colorectal cancer [ICD11:2B91]
Investigative
Gastric cancer [ICD11:2B72]
Investigative
|
|||||
Drug-to-Antibody Ratio |
3.6
|
|||||
Antibody Name |
Anti-FGFR2/4 mAb 12422
|
Antibody Info | ||||
Antigen Name |
Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)
|
Antigen Info | ||||
Payload Name |
Mertansine DM4
|
Payload Info | ||||
Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
Linker Name |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
|
Linker Info |
General Information of The Activity Data Related to This ADC
Full List of Activity Data of This Antibody-drug Conjugate
Revealed Based on the Cell Line Data
Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) | 0.07 nM | Positive FGFR2 expression (FGFR2+++/++) | ||
Method Description |
Cells were counted and seeded in 96 well plates at densities of 2600-3600 cells/well in 100 ul of cell culture medium, A duplicate plate was generated for a day 0 measurement and all plates were incubated in a tissue culture incubator at 37°C with 5% CO2 overnight. Following this incubation, 50 ul/well of Cell titer Glo reagent was added to the day 0 plates, which were then shaken gently for 10 min and the resulting luminescence intensity was measured.
Click to Show/Hide
|
||||
In Vitro Model | Gastric adenocarcinoma | SNU-16 cells | CVCL_0076 |
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.